David Smith is a Partner at Fasken Martineau LLP and is a member of the Corporate / Commercial practice group.
David's practice focuses on capital markets and a combination of capital raising and mergers and acquisitions. He also regularly represents entrepreneurial growing companies, both public and private. David has been actively involved in the Alternative Investment Market (AIM) since its inception in 1995, and has acted as company secretary to a number of listed and AIM companies.
David is a skilled communicator who aims to provide practical advice that is sensitive to the needs of his clients at a time when they need cool, calm counsel. He also recognizes the importance of balancing the sophisticated and sometimes taxing demands and business practices of capital providers with the needs of his entrepreneur clients, whose desires are generally focused more on concluding a transaction than on technical detail.
While David represents clients across industries ranging from television to information technology, his practice has some emphasis on the health sciences and natural resources sectors; to that end, he has lectured and written on the application of royalty financing securitization structures in the pharmaceutical industry. He has a growing cleantech practice, particularly in the field of solar power.
Honours and Awards
- David is recognised in Legal 500 2011 directory for his expertise in Corporate and Commercial – Flotations: Small and Mid-Cap, and for his expertise in TMT – Pharmaceuticals and Biotechnology; "clients appreciate…David Smith's 'sage advice and razor-sharp intellect'."
- David is listed in Legal Experts 2007/2010/2011, published by Legal Business, as an authority on Corporate, M&A.
- David is mentioned in Chambers UK legal directory 2010 as a 'Leader in his field'. David is recommended in Life Sciences: Commercial/Corporate; "David Smith is another corporate lawyer with a life sciences specialism, who is recommended by clients for his decades of experience and high-calibre work.
- David is recognised in the PLC Which Lawyer? Yearbook 2009, published by Practical Law for his expertise in Capital Markets: Equity (small-mid cap).
- David is mentioned in Chambers UK legal directory 2009 as a 'Leader in his field'. David is recommended in Life Sciences: Commercial/Corporate.
- David is recognised in the Capital Markets 2007/8 handbook, published by Practical Law for his expertise in Equity capital markets: small-mid cap. David "acts for a number of companies in AIM-related transactions", and "has a wealth of experience in this area".